Literature DB >> 18432984

Experimental autoimmune encephalomyelitis in the mouse.

Stephen D Miller1, William J Karpus.   

Abstract

This unit details the materials and methods required for both active induction and adoptive transfer of experimental autoimmune encephalomyelitis (EAE) in the SJL mouse strain using intact proteins or peptides from the two major myelin proteins: proteolipid protein (PLP) and myelin basic protein (MBP). Detailed materials and methods required for the purification of both PLP and MBP are also described. Modifications of the specified protocols may be necessary for efficient induction of active or adoptive EAE in other mouse strains.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18432984      PMCID: PMC2915550          DOI: 10.1002/0471142735.im1501s77

Source DB:  PubMed          Journal:  Curr Protoc Immunol        ISSN: 1934-3671


  69 in total

1.  Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis.

Authors:  Eileen J McMahon; Samantha L Bailey; Carol Vanderlugt Castenada; Hanspeter Waldner; Stephen D Miller
Journal:  Nat Med       Date:  2005-02-27       Impact factor: 53.440

2.  Acquisition of functional MHC class II/peptide complexes by T cells during thymic development and CNS-directed pathogenesis.

Authors:  Mindi R Walker; Mark D Mannie
Journal:  Cell Immunol       Date:  2002 Jul-Aug       Impact factor: 4.868

Review 3.  Genetics of experimental autoimmune encephalomyelitis in the mouse.

Authors:  Asa Andersson; Jenny Karlsson
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2004 Sep-Oct       Impact factor: 4.291

4.  Spontaneous opticospinal encephalomyelitis in a double-transgenic mouse model of autoimmune T cell/B cell cooperation.

Authors:  Gurumoorthy Krishnamoorthy; Hans Lassmann; Hartmut Wekerle; Andreas Holz
Journal:  J Clin Invest       Date:  2006-09       Impact factor: 14.808

5.  A neuropathological analysis of experimental autoimmune encephalomyelitis with predominant brain stem and cerebellar involvement and differences between active and passive induction.

Authors:  D M Muller; M P Pender; J M Greer
Journal:  Acta Neuropathol       Date:  2000-08       Impact factor: 17.088

6.  Chronologic neuropathology of relapsing experimental allergic encephalomyelitis in the mouse.

Authors:  A Brown; D E McFarlin; C S Raine
Journal:  Lab Invest       Date:  1982-02       Impact factor: 5.662

7.  Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis.

Authors:  B L McRae; C L Vanderlugt; M C Dal Canto; S D Miller
Journal:  J Exp Med       Date:  1995-07-01       Impact factor: 14.307

8.  Multiple discrete encephalitogenic epitopes of the autoantigen myelin basic protein include a determinant for I-E class II-restricted T cells.

Authors:  S S Zamvil; D J Mitchell; M B Powell; K Sakai; J B Rothbard; L Steinman
Journal:  J Exp Med       Date:  1988-09-01       Impact factor: 14.307

9.  IL-12 unmasks latent autoimmune disease in resistant mice.

Authors:  B M Segal; E M Shevach
Journal:  J Exp Med       Date:  1996-08-01       Impact factor: 14.307

Review 10.  Two models of multiple sclerosis: experimental allergic encephalomyelitis (EAE) and Theiler's murine encephalomyelitis virus (TMEV) infection. A pathological and immunological comparison.

Authors:  M C Dal Canto; R W Melvold; B S Kim; S D Miller
Journal:  Microsc Res Tech       Date:  1995-10-15       Impact factor: 2.769

View more
  76 in total

1.  Immune regulatory CNS-reactive CD8+T cells in experimental autoimmune encephalomyelitis.

Authors:  Nathan R York; Jason P Mendoza; Sterling B Ortega; Andrew Benagh; Andrew F Tyler; Mihail Firan; Nitin J Karandikar
Journal:  J Autoimmun       Date:  2010-02-20       Impact factor: 7.094

2.  Beneficial role of the GPR30 agonist G-1 in an animal model of multiple sclerosis.

Authors:  Eric Blasko; Christopher A Haskell; Stewart Leung; Giovanna Gualtieri; Meredith Halks-Miller; Mithra Mahmoudi; Megan K Dennis; Eric R Prossnitz; William J Karpus; Richard Horuk
Journal:  J Neuroimmunol       Date:  2009-08-06       Impact factor: 3.478

3.  Programmed Death-1 Culls Peripheral Accumulation of High-Affinity Autoreactive CD4 T Cells to Protect against Autoimmunity.

Authors:  Tony T Jiang; Tijana Martinov; Lijun Xin; Jeremy M Kinder; Justin A Spanier; Brian T Fife; Sing Sing Way
Journal:  Cell Rep       Date:  2016-11-08       Impact factor: 9.423

Review 4.  Neuroprotective effects of estrogens and androgens in CNS inflammation and neurodegeneration.

Authors:  Rory D Spence; Rhonda R Voskuhl
Journal:  Front Neuroendocrinol       Date:  2011-12-24       Impact factor: 8.606

Review 5.  The role of gut microbiome and associated metabolome in the regulation of neuroinflammation in multiple sclerosis and its implications in attenuating chronic inflammation in other inflammatory and autoimmune disorders.

Authors:  Nicholas Dopkins; Prakash S Nagarkatti; Mitzi Nagarkatti
Journal:  Immunology       Date:  2018-02-27       Impact factor: 7.397

6.  IL-11 antagonist suppresses Th17 cell-mediated neuroinflammation and demyelination in a mouse model of relapsing-remitting multiple sclerosis.

Authors:  Xin Zhang; Nazanin Kiapour; Sahil Kapoor; Joseph R Merrill; Yongjuan Xia; Woomi Ban; Stephanie M Cohen; Bentley R Midkiff; Valerie Jewells; Yen-Yu I Shih; Silva Markovic-Plese
Journal:  Clin Immunol       Date:  2018-08-24       Impact factor: 3.969

7.  Gastrointestinal hypomotility with loss of enteric nicotinic acetylcholine receptors: active immunization model in mice.

Authors:  J W Meeusen; K E Haselkorn; J P Fryer; T J Kryzer; S J Gibbons; Y Xiao; V A Lennon
Journal:  Neurogastroenterol Motil       Date:  2012-10-17       Impact factor: 3.598

8.  Towards programming immune tolerance through geometric manipulation of phosphatidylserine.

Authors:  Reid A Roberts; Timothy K Eitas; James D Byrne; Brandon M Johnson; Patrick J Short; Karen P McKinnon; Shannon Reisdorf; J Christopher Luft; Joseph M DeSimone; Jenny P Ting
Journal:  Biomaterials       Date:  2015-08-20       Impact factor: 12.479

9.  The nucleotide-binding leucine-rich repeat (NLR) family member NLRX1 mediates protection against experimental autoimmune encephalomyelitis and represses macrophage/microglia-induced inflammation.

Authors:  Timothy K Eitas; Wei-Chun Chou; Haitao Wen; Denis Gris; Gregory R Robbins; June Brickey; Yoshitaka Oyama; Jenny P-Y Ting
Journal:  J Biol Chem       Date:  2013-12-23       Impact factor: 5.157

Review 10.  Tristetraprolin as a Therapeutic Target in Inflammatory Disease.

Authors:  Sonika Patial; Perry J Blackshear
Journal:  Trends Pharmacol Sci       Date:  2016-08-05       Impact factor: 14.819

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.